U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07166302) titled 'Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy' on Sept. 03.
Brief Summary: Approximately 30 minutes after needle EMG, patients who are taking direct oral anticoagulants (DOACs) will undergo an ultrasound examination to evaluate for the presence of possible intramuscular hematomas at the muscles where the EMG needle was inserted. These hematomas are considered a potential adverse effect of needle EMG.
The aim of the study is to determine whether needle EMG can be considered a safe procedure in this group of patients, without posing a risk of intramuscular hematoma formation.
Study Start Date: S...